Tissue Regenix Group Plc (TRX) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.11x

Tissue Regenix Group Plc (TRX) has a Cash Flow Reinvestment Rate of 0.11x as of December 2023, reinvesting GBX153.75K (capex GBX153.75K ) from operating cash flow of GBX1.36 Million. See TRX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.11x

(Capex + Investments) / Operating CF

Total Reinvested

GBX153.75K

Capex + Investments

Operating Cash Flow

GBX1.36 Million

GBX

Capital Expenditures

GBX153.75K

GBX

Tissue Regenix Group Plc Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for Tissue Regenix Group Plc across 1 annual periods. For the full cash flow conversion analysis, see Tissue Regenix Group Plc cash flow conversion.

Annual Cash Flow Reinvestment Rate for Tissue Regenix Group Plc (2023–2023)

Year-by-year capital reinvestment analysis for Tissue Regenix Group Plc. See financial flexibility index of Tissue Regenix Group Plc to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (GBX)	Operating CF	Capex	YoY Change
2023	1.63x	GBX1.70 Million	GBX1.04 Million	GBX863.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow